Skip to content | Change text size



Hopper I, Skiba M, von Lueder TG, Watanabe M, Funston R, Tonkin A, Krum H.  Digoxin Withdrawal Worsens Clinical Status in Stable Patients With Heart Failure Receiving Optimal Contemporaneous Therapy-A Randomized Controlled Trial.  J Card Fail. 2015 Sep;21(9):779-81.

Girerd N, Collier T, Pocock S, Krum H, McMurray JJ, Swedberg K, Van Veldhuisen DJ, Vincent J, Pitt B, Zannad F.  Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.  Eur Heart J. 2015 Sep 7;36(34):2310-7.

Gorcsan J 3rd, Sogaard P, Bax JJ, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial.  Eur Heart J 2015 Aug 30 [Epub ahead of print] Review

Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, Traverse JH, Krum H, Skerrett D, Zheng Y, Willerson JT, Itescu S, Henry TD.  A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure.  Circ Res. 2015 Aug 28;117(6):576-84.

Steffel J, Robertson M, Singh JP, Abraham WT, Bax JJ, Borer JS, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, Brugada J, Ruschitzka F.  The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial.  Eur Heart J 2015 Aug 7;36(30):1983-89.

Krum H, Hopper I. The ongoing evolution of optimal clinical endpoints for heart failure trials.  JACC Heart Fail 2015 Aug;3(8):615-7.

Polhemus DJ, Li Z, Pattillo CB, Goodchild TT, Gojon G Sr, Cojon G Jr, Giordano T, Krum H.  A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients.  Cardiovasc Ther 2015 Aug;33(4):216-26.

Cannon JA, Collier TJ, Shen L, Swedberg K, Krum H, Van Veldhuisen DJ, Vincent J, Pocock SJ, Pitt B, Zannad F, McMurray JJ.  Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF). Eur J Heart Fail. 2015 Jul;17(7):707-16.

Chowdhury EK, Langham RG, Ademi Z, Owen A, Krum H, Wing LM, Nelson MR, Reid CM; Second Australian National Blood Pressure Study Management Committee.  Rate of change in renal function and mortality in elderly treated hypertensive patients.  Clin J Am Soc Nephrol 2015 Jul 7;10(7):1154-61.

Starling RC, Krum H, Bril S, Tsintzos SI, Rogers T, Hudnall JH, Martin DO.  Impact of a novel adaptive optimization algorithm on 30-day readmissions: Evidence from the Adaptive CRT Trial.  JACC Heart Fail 2015 Jul;3(7):565-72.

Eikelis N, Hering D, Marusic P, Sari C, Walton A, Phillips S, Lambert E, Duval J, Krum H, Lambert G, Esler M, Schlaich M.  The effect of renal denervation on endothelial function and inflammatory markers in patients with resistant hypertension.  Int J Cardiol 2015 Jun 1;188:96-98.

Gilbert RE, Krum H.  Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.  Lancet 2015 May 23;385(9982):2107-17. Review.

Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H.  Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis.  Int J Cardiol 2015 May 1;186:104-105.

Rana I, Kompa AR, Skommer J, Wang BH, Lekawanvijit S, Kelly DJ, Krum H, Charchar FJ.  Contributions of microRNA to pathological fibrosis in cardiorenal syndrome: impact of uremic toxins.  Physiol Rep 2015 Apr;3(4) e12371.

Chang S, Davidson PM, Newton PJ, Macdonald P, Carrington MJ, Marwick TH, Horowitz JD, Krum H, Reid CM, Chan YK, Scuffham PA, Sibbritt D, Stewart S; WHICH Investigators.  Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: A comparative assessment.  Int J Cardiol 2015 Apr 15;185:62-68.

Vinh NB, Devine SM, Munoz L, Ryan RM, Wang BH, Krum H, Chalmers DK, Simpson JS, Scammells PJ.  Design, synthesis, and biological evaluation of tetra-substituted thiophenes as inhibitors of p38a MAPK.  Chemistry Open 2015 Feb;4(1):56-64.

Chowdhury EK, Langham RG, Owen A, Krum H, Wing LM, Nelson MR, Reid CM; on behalf of the Second Australian National Blood Pressure Study Management Committee.  Comparison of predictive performance of renal function estimation equations for all-cause and cardiovascular mortality in an elderly hypertensive population.  Am J Hypertens 2015 Mar;28(3):380-6.

Lekawanvijit S, Krum H.  Cardiorenal syndrome: Role of protein-bound uremic toxins. J Ren Nutr 2015 Mar;25(2):149-154.

Metra M, Cotter G, El-Khorazaty J, Davison BA, Milo O, Carubelli V, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Rainisio M, Kobrin I, McMurray JJ, Teerlink JR.  Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study.  J Card Fail 2015 Mar;21(3):179-88.

Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Hawley CM, Isbel NM, Krum H, Pascoe EM, Tonkin AM, Vergara LA, Perkovic V; BLOCADE study collaborative group.  The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study.  Nephrology (Carlton). 2015 Mar;20(3):140-7.

Pitt B, Anker SD, Böhm M, Gheorghiade M, Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Nowack C, Kim SY, Pieper A, Kimmeskamp-Kirschbaum N, Filippatos G. Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease. Eur J Heart Fail 2015; Feb;17(2):224-32.

Patel HC, Hayward C, Ozdemir BA, Rosen SD, Krum H, Lyon AR, Francis DP, di Mario C.  Magnitude of blood pressure reduction in the placebo arms of modern hypertension trials: implications for trials of renal denervation.  Hypertension 2015 Feb;65(2):401-406.

Bodey F, Hopper I, Krum H.  Neprilysin inhibitors preserve renal function in heart failure.  Int J Cardiol 2015 Jan 20;179:329-30.

Von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H.  The angiotensin-receptor neprilysin inhibitor LCZ696 attenuates cardiac remodelling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.  Circ Heart Fail 2015;Jan 8(1):71-78.

Krum H.  Prospective comparison of ARNi with ACE-I to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF): Paragon of a study or further investigation paramount?  Circulation 2015 Jan 6;131(1):11-12.

Narayan O, Davies JE, Hughes AD, Dart AM, Parker KH, Reid C, Cameron JD. Central Aortic Reservoir-Wave Analysis Improves Prediction of Cardiovascular Events in Elderly Hypertensives. Hypertension 2015, Mar; 65(3):629-35.

Harding JL, Shaw JE, Anstey KA, Adams R, Balkau B, Brennan-Olsen SL, Briffa T, Davis TME, Davis WA, Dobson A, Flicker L, Giles G, Grant J, Huxley R, Knuiman M, Luszcz M, MacInnis RJ, Mitchell P, Pasco JA, Reid CM, Simmons DM, Simons L, Tonkin A, Woodward M, Peeters A & Magliano DJ.  Comparison of anthropometric measures as predictors of cancer incidence: a pooled collaborative analysis of 11 Australian cohorts Int J Cancer 2015:Oct 1;137(7):1699-708.

Meller B, Cullen L, Parsonage WA, Greenslade JH, Aldous S, Reichlin T, Wildi K, Twerenbold R, Jaeger C, Hillinger P, Haaf P, Puelacher C, Kern V, Rentsch K, Stallone F, Rubini Gimenez M, Ballarino P, Bassetti S, Walukiewicz A, Troughton R, Pemberton CJ, Richards AM, Chu K, Reid CM, Than M, Mueller C. Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients.  International Journal of Cardiology April 1;184:208-15.

Chowdhury EK, Ademi Z, Moss J, Wing LMH and Reid CM on behalf of the Second Australian National Blood Pressure Study Management Committee. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.   Medicine 2015 Mar;94(9).

Ruwanpathirana T, Owen A, Reid CM.  Review on cardiovascular risk prediction.  Cardiovascular Therapeutics 2015 April 33(2):62-70.

McQuilten ZK, Andrianopoulos N, van de Watering L, Aubron C, Phillips L, Bellomo R, Pilcher D, Cameron P, Reid CM, Cole-Sinclair MF, Newcomb A, Smith J, McNeil JJ, Wood EM.  Introduction of universal prestorage leukodepletion of blood components, and outcomes in transfused cardiac surgery patients. J Thorac Cardiovasc Surg 2015 Jul;150(1):216-22.

Ruwanpathirana T, Owen A, Renzaho AM, Zomer E, Gambhir M, Reid CM.  Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling. Clin Exp Pharmacol Physiol. 2015 Jun;42(6):596-601.

Dhurandhar V, Saxena A, Parikh R, Vallely MP, Wilson MK, Butcher JK, Black DA, Tran L, Reid CM, Bannon PG. Outcomes of on-pump versus off-pump coronary artery bypass graft surgery in the high risk (AusSCORE > 5). Heart Lung Circulation.  2015 Feb 23.

Couper LT, Loane P, Andrianopoulos N, Brennan A, Nanayakkara S, Nerlekar N, Scott P, Walton AS, Clark DJ, Duffy SJ. Ajani AE, Reid C, Shaw JA; Melbourne Interventional Group (MIG) Investigators.  Utility of rotational atherectomy and outcomes over an eight-year period.  Catheter Cardiovasc Interv. 2015 Jul 8.

Lim HS, Andrianopoulos N, Sugumar H, Stub D, Brennan AL, Lim CC, Barlis P, Van Gaal W, Reid CM, Charter K, Sebastian M, New G, Ajani AE, Farouque O, Duffy SJ, Clark DJ, Melbourne Interventional Group.  Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.  Int J Cardiol. 2015 Sep 15,195:259-64.

Harding J, Sooriyakumaran M, Anstey KJ, Adams R, Balkau B, Briffa T, Davis TM, Davis WA, Dobson A, Giles GG, Grant J, Knuiman M, Luszcz M, Mitchell P, Pasco JA, Reid C, Simmons D, Simons L, Tonkin A, Woodward M, Shaw JE, Magliano DJ.  The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?  Diabetes Metab. 2015 May 30.

Ch'ng SL, Cochrane AD, Wolfe R, Reid C, Smith CI, Smith JA.  Procedure-specific cardiac surgeon volume associated with patient outcome following valve surgery, but not isolated CABG surgery.  Heart Lung Circ.  2015 Jun;2(6):583-9.

Thawornchaisit P, de Looze F, Reid CM, Seubsman S, Tran TT, Sleigh A & the Thai Cohort Study Team. Health-Risk Factors and the Prevalence of Chronic Kidney Disease: Cross-Sectional Findings from a National Cohort of 87 143 Thai Open University Students. Glob J Health Sci 2015 Feb 24;7(5):42289.




Cotter G, Metra M, Davison BA, Senger S, Bourge RC, Cleland JG, Jondeau G, Krum H, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Milo O, Kobrin I, Rainisio M, McMurray JJ, Teerlink JR for the VERITAS investigators.  Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail 2014; Dec 16(12):1362-71.

Fudim M, Stanton A, Sobotka PA, Dolan E, Krum H.  The thrill of success: central arterial-venous anastomosis for hypertension.  Curr Hypertens Rep 2014 Dec;16(12):497.

Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H.  Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve.  J Hypertens 2014 Nov;32(11):2158-2165.

D'Elia E, Krum H.  Mineralcorticoid antagonists in heart failure.  Heart Fail Clin 2014 Oct;10(4):559-564.

Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; on behalf of the Beta-Blockers in Heart Failure Collaborative Group.  Efficacy of beta-blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.  Lancet 2014 Dec 20;384(9961):2235-43. 

Krum H.  Decade in review - heart failure: 10 years of progress in HF research - what have we learned?  Nat Rev Cardiol 2014 Nov 11(11):631-633.

Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, Atherton J, Rahimzadeh S, Ghaziani M, Shaikh M, Bennett D, Patel A, Lam CS, Sliwa K, Barretto A, Siswanto BB, Diaz A, Herpin D, Krum H, Eliasz T, Forbes A, Kiszely A, Khosla R, Petrinic T, Praveen D, Shrivastava R, Xin D, MacMahon S, McMurray J, Rahimi K.  Heart failure care in low- and middle-income countries: a systematic review and meta-analysis.  PLoS Med. 2014 Aug 12;11(8):e1001699.

Krum H, Hopper I.  Statins in CHF.  Heart Lung Circ 2014 Oct;23(10):988.

Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, van Veldhuisen DJ, Vincent J, Pitt B, McMurray JJ; for the Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) Study.  Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms.  Heart 2014;100(21):1681-1687.

Kompa AR, Krum H.  Protein kinases as cardiovascular therapeutic targets.  Lancet 2014  Sept 27;384(9949):1162-1164.

Lekawanvijit S, Krum H.  Cardiorenal syndrome: Acute kidney injury secondary to cardiovascular disease and role of protein-bound uremic toxins.  J Physiol 2014 Sep 15;592(Pt 18):3969-3983. (Review)

Esler MD, Bohm M, Sievert H, Rump CL, Schmieder RE, Krum H, Mahfoud F, Schlaich MP.  Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.  Eur Heart J 2014;35(26):1752-1759.

Krum H, Sobotka P, Schlaich M, Bohm M, Esler M.  Renal denervation for resistant hypertension - the Symplicity HTN-1 study - Author's reply.  Lancet 2014;383(9932):1885-1886.

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Bohm M. Response to letter regarding article "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".  Circulation 2014;129(20):e500-501.

Von Lueder TG, Atar D, Krum H. Current role of neprilysin inhibitors in hypertension and heart failure.  Pharmacol Ther 2014 Oct;144(1):41-9. (Review)

Stewart S, Carrington MJ, Horowitz JD, Marwick TH, Newton PJ, Davidson PM, Macdonald P, Thompson DR, Chan YK, Krum H, Reid C, Scuffham PA.  Prolonged impact of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort. Int J Cardiol. 2014;174(3):600-610.

Sheerin NJ, Newton PJ, Macdonald PS, Leung DY, Sibbritt D, Spicer ST, Johnson K, Krum H, Davidson PM.  Worsening renal function in heart failure: The need for a consensus definition. Int J Cardiol. 2014;174(3):484-491. (Review)

Wu S, Hopper I, Skiba M, Krum H.  Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: Meta-analysis of randomized clinical trials with 55,141 participants.  Cardiovasc Ther 2014;32(4):147-158.

Hopper I, Samuel R, Hayward C, Tonkin A, Krum H.  Can medications be safely withdrawn in patients with stable chronic heart failure?  Systematic review and meta-analysis.  J Card Fail 2014;20(7):522-532. (Review)

Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.  Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.  Hypertension 2014;64(1):118-124.

Dworak M, Stebbing M, Kompa AR, Rana I, Krum H, Badoer E.  Attenuation of microglial and neuronal activation in the brain by ICV minocycline following myocardial infarction.  Auton Neurosci 2014 Oct;185:43-50.

Krum H, Skiba M, Wu S, Hopper I. Heart failure and dipeptidyl peptidase-4 inhibitors. Eur J Heart Fail 2014;16(6):603-607.

Ademi Z, Pasupathi K, Krum H, Liew D.  Cost effectiveness of eplerenone in patients with chronic heart failure.  Am J Cardiovasc Drugs 2014;14(3):209-216.

Peck KY, Lim YZ, Hopper I, Krum H.  Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: A meta-analysis of >35,000 patients.  Int J Cardiol 2014;173(2):197-203.

Chowdhury EK, Owen A, Krum H, Wing LM, Nelson MR, Reid CM.  Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients.  J Hypertens 2014;32(3):525-533.

Clark H, Krum H, Hopper I. Worsening renal function during RAAS inhibitor initiation and long term outcomes in patients with left ventricular systolic dysfunction. Eur J Heart Fail 2014;16(1):41-48.

Chang S, Newton PJ, Inglis S, Luckett T, Krum H, Macdonald P, Davidson PM.  Are all outcomes in chronic heart failure rated equally?  An argument for a patient-centred approach to outcome assessment.  Heart Fail Rev 2014;19(2):153-162.

Chowdhury EK, Owen A, Ademi Z, Krum H, Johnston CI, Wing LM, Nelson MR, Reid CM; Second Australian National Blood Pressure Study Management Committee.  Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the second Australian national blood pressure study.  Am J Hypertens 2014;27(2):199-206.

Krum H, Schlaich MP, Bohm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler M.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.  Lancet 2014;383(9917):622-629.

Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F.  Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo additional to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).  Circ Heart Fail 2014;7(1):51-58.

Brown A, Carrington MJ, McGrady M, Lee G, Zeitz C, Krum H, Rowley K, Stewart S. Cardiometabolic risk and disease in Indigenous Australians: The heart of the heart study.  Int J Cardiol 2014;171:377-383.

Xu J, Hering D, Sata Y, Walton A, Krum H, Esler MD, Schlaich MP.  Renal denervation: current implications and future perspectives.  Clin Sci (Lond) 2014;126(1):41-53.

Krum H. Current clinical trials of cell-based therapies in cardiac repair: too many variables spoil the stem cell broth. Eur Heart J 2014;35(15):955-957.

Damman K, Tang WH, Felker GM, Lassus J, Zannad F, Krum H, McMurray JJ. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: Practical considerations from published literature.  J Am Coll Cardiol 2014;63(9):853-871. (Review)

Ng SY, Sanagou M, Wolfe R, Cochrane A, Smith JA, Reid CM.  Prediction of acute kidney injury within 30 days of cardiac surgery. J Thorac Cardiovasc Surg. 2014 Jun;147(6),1875-83.

Kellow NJ, Coughlan MT, Reid CM. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr.  2014 Apr 14; 111 (7):1147-1161.

Reid CM, Yan B, Wan Ahmad WA, Bang LH, Hian SK, Chua T, Chan M, Beltrame J, Duffy SJ, Brennan A, Ajani A. The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) collaboration - Improving the quality of cardiovascular care in the Asia Pacific Region. Int J Cardiol.  2014 Mar 1;172(1):72-5.

McMurrick PJ; Oliva K; Carne P, Reid C; Polglase A; Bell S. Farmer K C, Ranchod, P. The First 1000 Patients on an Internet-based Colorectal Neoplasia Database Across Private and Public Medicine in Australia: Development of a Binational Model for the Colorectal Surgical Society of Australia and New Zealand. Dis Colon Rectum 2014 Feb; 57(2): 167-173.

Reid CM, Owen AJ, Freedman B.  Coronary artery disease epidemics: not all the same, Medicographia, 2014, 36(1): 11-18.

Sanagou M, Wolfe R, Leder K, Reid CM.  External Validation and updating of a Prediction Model for Nosocomial Pneumonia after Coronary Artery Bypass Graft Surgery. Epidemiol & Infect.  2014 Mar; 142(3): 540-4.

Than M, Flaws D, Sanders S, Doust J, Glasziou P, Kline J, Aldous S, Troughton R, Reid C, Parsonage WA, Frampton C, Greenslade JH, Deely JM, Hess E, Sadiq AB, Singleton R, Shopland R, Vercoe L, Woolhouse-Williams M, Ardagh M, Bossuyt P, Bannister L, Cullen L. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol.  Emerg Med Austral 2014 Feb; 26(1):34-44.

Sugumar H, Lancefield TF, Andrianopoulos N, Duffy SJ, Ajani AE, Freeman M, Buxton B, Brennan AL, Yan BP, Dinh DT, Smith JA, Charter K, Farouque O, Reid CM, Clark DJ. Australia and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) & Melbourne Interventional Group (MIG). Impact of Renal Function in Patients with Multi-vessel Coronary Disease on Long-Term Mortality Following Coronary Artery Bypass Grafting (CABG) compared With Percutaneous Coronary Intervention (PCI).  Int J Cardiol 2014 Mar 15;172(2):442-9.

Saxena A, Shi WY, Paramanathan A. Herle P, Dinh D, Smith JA,  Reid CM, Shardey G,  Newcomb AE.  A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery.  J Cardiovasc Med: 2014 Mar;15(3):199-206.

Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Rafter N, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.  Eur J Prev Cardiol. 2014 Mar 27.

Ademi Z, Liew D, Gorelik A, Bohensky M, Zomer E, Hollingsworth B, Steg G, Bhatt DL, Reid CM on behalf of the REACH Registry investigators. Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data.  International Journal of Cardiology 2014 Jul 15;;175(1):72-7.

Brennan AL, Andrianopoulos N, Duffy SJ, Reid CM, Clark DJ, Loane P, New G, Black A, Yan BP, Brooks M, Roberts L, Carroll EA, Lefkovits J, Ajani AE on behalf of the Melbourne Interventional Group Investigators. Trends in Door-to-Balloon Time and Outcomes Following Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: an Australian perspective.   Intern Med J 2014 May;44(5):471-7.

McQuilten ZK, Andrianopoulos N, Wood  EM, Cole-Sinclair MF, McNeil JJ, Cameron PA, Reid CM, Newcomb AE, Smith JA, Phillips LE.  Transfusion practice varies widely in cardiac surgery: results from a national registry. J Thorac Cardiovasc Surg 2014 May;147(5):1684-1690.

Cole JA, Brennan AL, Ajani AE, Yan BP, Duffy SJ, Loane P, Reid CM, Yudi MB, New G, Black A, Shaw J, Clark DJ, Andrianopoulos N.  Cardiovascular Medication Use Following Percutaneous Coronary Intervention: The Australian Experience. Cardiovasc Ther. 2014 Apr;32(2):47-51.

Billah B, Huq MM, Smith JA, Sufi F, Tran L, Shardey GC, Reid CM.  AusSCORE II in predicting 30-day mortality after isolated coronary artery bypass grafting in Australia and New Zealand. J Thorac Cardiovasc Surg 2014 Nov;148(5):1850-5.

Saxena A, Shan L, Reid C, Dinh D, Smith JA, Shardey GC, Newcomb AE. Impact of Smoking Status on Early and Late Outcomes after Isolated coronary artery bypass graft surgery. Journal of Cardiology  2013; 336-341.

Kellow NJ, Coughlan MT, Savige GS, and Reid CM. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trialBMC Endocr Disord 2014 Jul 10;14:55.

Shi WY, Yap CH, Newcomb AE, Hayward PA, Tran L, Reid CM, Smith JA. Impact of socioeconomic status and rurality on early outcomes and mid-term survival after CABG: Insights from a multicentre registry.  Heart, Lung & Circulation 2014; Aug;23(8):726-36.

Head GA, Andrianopoulos N, McGrath BP, Martin CA, Carrington MJ, Lukoshkova EV, Davern PJ, Jennings GL, Reid CM. Predictors Of Mean Arterial Pressure Morning Rate Of Rise And Power Function In Subjects Undergoing Ambulatory Blood Pressure Recording. PLoS One 2014; Mar 25; 9(3): e93186.

Ariyaratne TV, Ademi Z, Yap C-H, Billah B, Rosenfeldt F, Yan BP, Reid CM.  Prolonged effectiveness of Coronary Artery Bypass Surgery versus Drug-Eluting Stents in Diabetics with Multi-Vessel Disease: an updated systematic review and meta-analysis.  Int J Cardiol 2014; Sep 20; 176(2):346-53.

Russell EA, Tran L, Baker RA, Bennetts JS, Brown A, Reid CM, Tam R, Walsh WF, Maguire GP. A review of valve surgery for rheumatic heart disease in Australia. BMC Cardiovascular Disorders 2014,Oct 2; 14:134.

Coulson TG, Bailey M, Reid CM, Tran L, Mullany DV, Smith JA, Pilcher D. Acute Risk change for Cardiothoracic admissions to Intensive Care: (ARTIC Index) A New Measure of Quality in cardiac surgery.   The Journal of Thoracic and Cardiovascular Surgery 2014, Dec;148(6):30 76-81.

Aldous SJ, Richards AM, George PM, Cullen L, Parsonage WA, Flaws D, Florkowski CM, Troughton RW, O'Sullivan JW, Reid CM, Bannister L, Than M.  Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction.  Int  J Cardiol  2014, Nov 15;177(1):182-6.

Ruwanpathirana T, Reid CM, Owen A, Fong DPS, Gowda U, Renzaho AMN. Assessment of vitamin D and its association with cardiovascular disease risk factors in an adult migrant population: An audit of patient records at a Community Health Centre in Kensington Melbourne, Australia. BMC Cardiovascular Disorders 2014;14:157.

Huynh QL, Reid CM, Chowdhury EK, Huq MM, Billah B, Wing LMH, Tonkin AM, Simons LA, Nelson MR on behalf of the Second Australian National Blood Pressure Management Committee. Prediction Of Cardiovascular And All-Cause Mortality At 10 Years In The Hypertensive Aged Population. Am J Hypertension 2014, Nov 14.

Laba TL, Hayes A, Serigne Lo, Peiris DP, Usherwood T, Hillis GS, Rafter N, Reid CM, Tonkin AM, Webster R, Neal BC, Cass A, Patel A, Rodgers A, Jan S, for the Kanyini Guidelines Adherence with the Poly-pill (Kanyini GAP) Collaboration. An economic case for a cardiovascular poly-pill? A cost analysis of the Kanyini GAP trial. MJA 2014, Dec 11;201(11):671-3.

Chellappah J, Tonkin A, Douglas Gregg, ME, Reid CM.   A randomised controlled trial of effects of fruit intake on cardiovascular disease risk factors in children. (FIST Study) ICAN: Infant, Child and Adolescent Nutrition 2014; Vol 7 (1): 15-23.

Saxena A, Shan L, Reid CM, Smith JA, Shardey GC, Newcomb AE.  Impact of smoking status on outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery.  Thoracic and Cardiovascular Surgeon 2014; Feb 62(1): 52-59.